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Spectroscopic and mechanistic studies of dinuclear
metallohydrolases and their biomimetic complexes
Lena J. Daumann,a Gerhard Schenk,a David L. Ollisb and Lawrence R. Gahan*a
An enhanced understanding of the metal ion binding and active site structural features of phospho-
esterases such as the glycerophosphodiesterase from Enterobacter aerogenes (GpdQ), and the organo-
phosphate degrading agent from Agrobacterium radiobacter (OpdA) have important consequences for
potential applications. Coupled with investigations of the metalloenzymes, programs of study to syn-
thesise and characterise model complexes based on these metalloenzymes can add to our understanding
of structure and function of the enzymes themselves. This review summarises some of our work and illus-
trates the significance and contributions of model studies to knowledge in the area.
1. Introduction
The current knowledge about the structure, function, and
mechanism of dinuclear metallohydrolases has been summar-
ised by a number of authors.1–7 Metallohydrolases are of con-
siderable interest by virtue of their biological roles and their
use in bioremediation. In some cases, their roles make them
targets for drug design against a variety of human disorders
while in other cases their catalytic activities make them ideal
reagents for the bioremediation of organophosphate pesticides
and nerve agents.1–6,8–13 In addition, the capacity for mimicry
of their properties through model complexes makes them
attractive to the bioinorganic chemist.14–34 In this perspective
we firstly describe the general classes of metallohydrolases, we
review the properties of two organophosphate-hydrolysing
metalloenzymes of interest to our research and discuss the
various model complexes of divalent metal ions synthesised in
order to probe the structure, function and spectroscopic pro-
perties of the metalloenzymes.
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2. Dinuclear metallohydrolases
The family of dinuclear metallohydrolases comprises a large
number of enzymes with very different functionalities
(Table 1). The dual action of two metals can have different
advantages over catalysis by just one metal ion.35 These advan-
tages include that the thermodynamic driving force for redox
reactions is lowered due to charge-delocalization; as well, the
activation barrier is also lowered for solvent and enzyme re-
organization.35 In addition, substrates can be more effectively
oriented and the electrostatic activation of substrates is more
easily achieved.35 Furthermore, two metal ions facilitate the
formation of hydrolysis-initiating nucleophiles more readily,
and lower lying energy transition states for hydrolysis reactions
can be achieved.35 The metal ion content and oxidation states
of the dinuclear metallohydrolases are as diverse as their pro-
posed mechanisms, nucleophiles and substrates utilized.
Phosphoesterases such as the glycerophosphodiesterase
from Enterobacter aerogenes (GpdQ), the organophosphate-
degrading agent (OpdA) from Agrobacterium radiobacter and
the phosphotriesterase (PTE) from Pseudomonas diminuta have
attracted attention due to their ability to degrade toxic pesti-
cides, whereas for the purple acid phosphatases (PAPs),
metallo-β-lactamases (MβLs) and ureases the interest is mainly
due to their role in human disorders and therapy.7,36,37 The
active site structures of dinuclear metallohydrolases typically
have the metal ions coordinated to histidine, glutamic acid,
aspartate, asparagine and (carboxylated) lysine amino acid
residues, in addition to terminal or bridging water/hydroxide
ligands. The two metal binding sites are often defined as
the α- and β-site, differentiated by their coordination
environments.38
In this review we focus on the dinuclear metalloenzymes
OpdA and, in particular, GpdQ. OpdA is an extremely efficient
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Table 1 Overview of hydrolytic metalloenzymes
Enzyme Metal ion composition Biological function Research incentive
Glycerophospho-diesterase
(GpdQ)8,11,38,41,42,77–80
Fe(II)–Zn(II), Co(II)–Co(II),
Mn(II)–Mn(II), Cd(II)–Cd(II)
Hydrolysis of 3′-5′ phosphodiester
bond of glycerophosphodiesters
Potential bioremediator
Purple acid phosphatases
(PAP)191–199
Fe(III)–Fe(II), Fe(III)–Mn(II),
Fe(III)–Zn(II)
Bone metabolism (animals) and
phosphate uptake (plants)
Target for anti-osteoporotic drugs
Metallo-β-lactamases117 Zn(II)–Zn(II) Hydrolysis of β-lactam substrates
(antibiotics)
Study potential inhibitors to fight
antibiotic resistance
Rv080539,40 Fe(III)–Mn(II)a Cleavage of cAMP/cGMP
phosphodiester bonds
Potential bioremediator
Phosphotriesterases
(OpdA, OPH)49,64,68,71
Co(II)–Co(II), Mn(II)–Mn(II),
Cd(II)–Cd(II), Fe(II)–Zn(II)
Organophosphate hydrolysis Potential bioremediator
Ureases200 Ni(II)–Ni(II) Hydrolysis of urea Treatment of bacterial infections,
regulation of nitrogen uptake in plants
Ser/Thr phosphatase2,191 Fe(II)–Fe(II), Fe(II)–Zn(II),
Mn(II)–Mn(II)
Gene expression Target in chemotherapy
Leucine aminopeptidases201 Zn(II)–Zn(II) Amino acid synthesis Target for drugs against leukemia
Arginase35,202 Mn(II)Mn(II) Hydrolysis of Arginine Involved in vascular diseases
a Proposed in vivo.
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phosphotriesterase with low levels of activity towards phospho-
diesters. GpdQ rapidly degrades a variety of phosphodiesters
and has weak activity towards mono- and triphosphate ester
substrates. Attempts to duplicate the catalytic, spectroscopic
and mechanistic properties of phosphoesterases have been
one of our goals, and the goals of many other workers in the
area.14–29 The metal ions of special interest in our own work
(zinc(II), cobalt(II) and cadmium(II)) will be discussed. We
acknowledge (i) the contributions of all previous authors upon
which our contributions are built on, and (ii) the efforts of
contemporary researchers in our area, whose work parallels
ours. The review is selective in its coverage and we extend our
apologies to everyone whose contributions may not have been
covered by this review.
3. Phosphoesterases in general
Phosphoesterases are ubiquitous in nature. Amongst other
activities they are involved in signal transduction in bacteria
(Rv0805),39,40 phospholipid degradation (GpdQ),8,41,42 as well
as regulation of phosphate levels in plants, fungi and
mammals (PAPs).2,36,43–47 Some phosphoesterases such as the
organophosphate-degrading agent OpdA have apparently
recently evolved due to the widespread use of organophosphate
pesticides.48,49 Another well studied enzyme of this type is the
PTE from P. diminuta and Flavobacterium species, which is also
known under the name OPH (organophosphorus hydro-
lase).50,51 It is proposed that these enzymes provide bacteria
living in soil with essential nutrients like phosphate by hydro-
lysing pesticides. These enzymes have attracted attention as
they are also able to hydrolyse highly toxic organophosphate
nerve agents.8–11
3.1 Organophosphates
In developing countries especially, the benefits of pesticides
have to be compared with the risks involved with handling
and applying them. The question is how to eliminate the resi-
dues of these compounds from the environment to avoid
hazards for aquatic organisms and human health?52–55 As well
as use as pesticides, OPs have also been used as nerve agents,
for example, sarin or VX.54 It is proposed that the mode of
action of these compounds involves the organophosphate
molecule undergoing nucleophilic attack by a serine-OH
moiety in the active site of the enzyme acetylcholine esterase
(AChE), subsequently blocking the site for the neurotransmit-
ter acetylcholine.54,55 With the enzyme inhibited, acetylcholine
builds up in the synapses and nerve impulses are continually
transmitted. The resulting dysfunction of the parasympathetic
nervous system may lead to the death of the organism. Fig. 1
shows some examples of organophosphates used as pesticides
and nerve agents.54–57 Most pesticides bear a P = S moiety,
whereas nerve agents contain the P = O motif. Thiophosphates
are less potent AChE inhibitors than the corresponding oxo-
phosphates.54,55 This is due to the former being more stable
and thus less likely to react with AChE. However, desulfuriza-
tion in vivo leads to a high acute toxicity of the thiophosphate
pesticides.58 A typical example is the conversion of parathion
to paraoxon. Mesomeric and inductive effects of substituents
affect the stability and electrophilicity further; electron with-
drawing groups/atoms such as fluorine enhance the reactivity
of the phosphorus and thus the toxicity and AChE inhibitory
effects.58 The phosphate ester bond is prone to cleavage,
mostly by hydrolysis, but photolytic degradation by sunlight is
also possible;59 however, biological pathways for decontamina-
tion have also attracted attention.11,53,60–62
3.2 The phosphotriesterase OpdA
OpdA is one of the most efficient enzymes known to degrade
phosphate triesters, working at near diffusion limited rates
towards favored substrates.49 It has been commercially intro-
duced to Australia by CSIRO and Orica Watercare under the
name Landguard™ OP-A, as bioremediator in agriculture
(treatment of sheep dip, water run-off and soil contami-
nation).63,64 Landguard™ OP-A is capable of degrading
common pesticides like chlorpyriphos or diazinon and is to
date the only enzyme-based product for pesticide bioremedia-
tion in Australia. Therapeutic use of OpdA against OP poison-
ing has also been recently demonstrated.65–67 For example, rats
poisoned with a lethal dose of the pesticide dichlorvos showed
100% survival after OpdA was included in the treatment.65 The
pharmacokinetics of this enzyme has also been studied in the
African green monkey to develop new therapeutic approaches
for OP poisoning.66 OpdA has a similar active site to OPH with
a more buried 5-coordinate α-site in the resting state, and a
Fig. 1 Phosphoesters that have been used as nerve agents or pesticides.
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more solvent exposed 6-coordinate β-site.49,68–71 The metals
are bridged by a carboxylated lysine residue in addition to a
µ-hydroxide. The active site of OpdA is shown in Fig. 2 along
with the overall structure of the enzyme. The native metal ion
content in vivo is currently unknown for this enzyme and
depending on the metal ion composition; OpdA displays a
high mechanistic flexibility for OP degradation.71 This
mechanistic flexibility might be important for a rapid evolu-
tion of OpdA towards environmental changes. For the Zn(II)
and Cd(II) derivatives one kinetically relevant protonation equi-
librium was observed in ethyl paraoxon hydrolysis at a low pKa
range of around 4–5, as expected for a µ-hydroxide.71 For the
Co(II) derivative however, a terminal hydroxide is the proposed
nucleophile.71 Although OpdA is an extremely efficient enzyme
it has drawbacks. The pH optimum is at a very limited pH
range (so the pH has to be adjusted in many cases before
water treatment to use the full potential of the enzyme), and it
is only capable of degrading triester substrates. It also lacks
stability which is essential for a bioremediator.
3.3 Discovery of GpdQ and its overall structure
The ability of GpdQ to degrade a variety of stable phosphate
diesters first came to attention in the 1970s when Gerlt and
co-workers purified GpdQ and investigated its function.72 The
natural substrate is glycerol-phosphoethanolamine72 but
GpdQ is reported to be also able to degrade other phospho-
diester substrates along with phosphomonoester, phosphotri-
ester and phosphorothiolate substrates (Fig. 3).8,42,73,74 Its
potential as bioremediator for nerve agents was noted in 2007
when Raushel reported the GpdQ-catalysed degradation of EA
2192, a degradation product of the nerve agent VX.8 The crystal
structure of GpdQ was first solved by Ollis and co-workers.41,42
A structure with higher resolution (1.9 Å) is, however, now avail-
able.38,75 The structure shows that GpdQ is a hexamer which
consists of a trimer of dimers, having overall D3 symmetry.
38
Fig. 4 displays the hexamer (a) and the structure of the dimeric
subunit (b). Each dimer is comprised of a cap domain
(yellow), a dimerisation domain shown in red and two catalytic
domains (blue), each of them hosting a dinuclear active site.
The active site in the resting state is mononuclear with only
the six-coordinate α-site being occupied by a metal ion.38
In an attempt to evolve GpdQ towards the non-physiological
substrate bis(4-nitrophenyl)phosphate (BPNPP) a range of
mutants were obtained by directed evolution.76 These mutants
exhibited increased activity towards BPNPP and the previously
found hexameric structure was broken down in some
mutants.76 The mutation of a cysteine residue (C269) in the
dimerization domain led to the formation of monomer and
dimer forms of GpdQ. The smaller oligomeric (dimer) forms
of GpdQ were shown to have enhanced activity towards bis(2,4-
dinitrophenyl)phosphate (BDNPP) compared to the wild type
form. For example, the 8–3 mutant dimer (8th generation)
showed an over 500-fold higher catalytic efficiency compared
to the wild type.76 This was attributed to the opening of the
active site towards solvent and substrate molecules.76 The
more recent crystal structure at higher resolution illustrates an
extensive hydrogen bonding network in the metal binding
active site connecting it with the second coordination
sphere.38,75 The α-site features four amino acid side chains,
two aspartates (Asp50, Asp8) and two histidines (His10,
His197), whereas the metal in the β-site, vacant in the resting
state, is coordinated by two histidines (His156, His195), one
aspartate (Asp50) and one asparagine (Asn80).75,77,78 The
crystal structure also suggests the presence of a terminal H2O
Fig. 3 Physiological substrate of GpdQ and other phosphoesters used in kinetic assays.8,38,72–74
Fig. 2 Overall structure of OpdA (left) and active site (right). PDB number 2D2G.186,187
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bound to the α-metal and a bridging water/hydroxide mole-
cule. The in vivo metal ion content in GpdQ has, to date, not
been determined, although studies using anomalous scatter-
ing experiments suggest Fe(II) bound in the α-site.75 Catalytic
activity can be reconstituted with a variety of divalent metal
ions including Co(II), Zn(II), Fe(II), Mn(II) and Cd(II),75,79,80 and
heterodinuclear derivatives of GpdQ have been reported in an
attempt to explore the in vivo metal ion content.75,81 As Co(II)
serves as an excellent spectroscopic probe, the Co(II)Co(II)
derivative is the most well studied metal derivative.77,78 Given
the potential use of GpdQ in bioremediation much work has
been undertaken to understand (i) the nature of its reaction
mechanism, and (ii) factors which influence substrate-and
metal ion binding.
4. Catalytic mechanism of GpdQ
We, and others, have made extensive use of magnetic circular
dichroism (MCD) to probe the mechanism as well as the geo-
metric and electronic structure of biological metal systems and
the metal binding sites.68,78,82–86 MCD measures the differen-
tial absorption of left and right circular polarised light, similar
to circular dichroism (CD), but in the presence of a magnetic
field.84 Application of a magnetic field parallel to the direction
of light causes all matter to exhibit MCD activity so it is not
restricted to paramagnetic materials.84 Zero-field splitting,
g-tensors and spin states can also be obtained, in addition to
magnetic coupling interaction information for dimetallic sites,
by analysing variable temperature, variable field (VTVH)
data.84,87,88 MCD studies of Co(II)2-GpdQ, have revealed the
two distinct binding sites, a 6-coordinate site with high affinity
and a 5-coordinate site with low affinity.38,78 These studies
showed that GpdQ exists as a mononuclear resting state
enzyme with only the α-site occupied by metal, as evidenced
by the single band in the MCD spectrum at 495 nm (typical for
6-coordinate Co(II)).38,75 Upon binding of substrate it is pro-
posed that the active site (EM′·S) (Fig. 5) undergoes rapid struc-
tural rearrangement facilitated by the hydrogen bond network
that connects the first and second coordination sphere.79 The
studies demonstrated that the dinuclear Co(II)Co(II) metal
centre in GpdQ is only formed in the presence of a substrate
or in this case phosphate, a substrate analogue (EB·S).
29,79 The
fact that bands from 5- and 6-coordinate Co(II) were observed
in the MCD led to the proposal that the bond between Co(II)
and Asn80 in the β-site is broken upon substrate coordination
(EB
*·S).38,75,79 A terminal hydroxide then acts as nucleophile,
product and the β-metal are released and the active site
returns to its mononuclear resting state.38,79 The formation of
a dinuclear centre in the presence of substrate was substan-
tiated by electron paramagnetic resonance (EPR) spectroscopic
studies of the Mn(II)Mn(II) derivative of GpdQ.79 EPR data
Fig. 4 Hexamer of GpdQ (left) and active site structure (right). PDB number 3D03.38,186
Fig. 5 Proposed mechanism of hydrolysis of phosphate esters by GpdQ (determined from stopped-flow fluorescence studies, picture taken from
ref. 79).
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revealed Kd values for the metal ions in the α- and β-sites to be
29 and 344 μM, respectively, in the absence of a substrate
analog.79 In the presence of phosphate the affinity of the β-site
increased significantly (Kd = 56 μM).79 The metal ion affinity of
the β-site can be increased by changing the Asn80 residue to
an aspartate, resulting in a fully occupied dinuclear centre
after the addition of two equivalents of Co(II) to the apo-
enzyme, even in the absence of substrate.75 However, the
enzyme activity was impaired as shown by kinetic measure-
ments, leading to the proposal that the coordination flexibility
of Asn80 is required for high activity. The exchange of Asn80
by alanine led to a dinuclear centre only in the presence of
substrate.75 Also, this mutant showed increased reactivity
while its affinity for substrate was greatly decreased. Further
studies with GpdQ mutants have been conducted to elucidate
the role of the surrounding hydrogen bond network.79 Specifi-
cally, the role of His81 and His217 has been probed by repla-
cing these residues by alanine in site directed mutagenesis
experiments.79 While replacement with alanine did not affect
the pH dependence of the enzyme, an increased metal binding
affinity resulted, being 2- (His81Ala) and 8-times (His217Ala)
higher than in wt-GpdQ.79 This shows that residues that are
not directly interacting with the active site metal ions have an
impact on the coordination environment through the hydro-
gen bond network.
5. Biomimetics of dinuclear
metallohydrolases
The study of biomimetics can be of considerable benefit for
the understanding of enzymatic reactions. The term bio-
mimetic refers here to a compound that mimics structural,
functional and spectroscopic properties of an enzyme.33,34
Often only one or two of these aspects are achieved for a
model system and they usually display substantially lower
activity. There are, however, advantages over the enzyme:
model complexes are generally more stable and robust than
their enzymatic counterpart, they can be readily crystallised
and provide easy accessible structural information on metal
ion coordination. Further, the model systems are considerably
less complex, kinetic and spectroscopic data interpretation is
simplified and – by comparison to data derived for the enzyme
– the mechanism of action and structural features can be eluci-
dated and thus related to the metalloenzyme. Ligand and
complex design in biomimetic systems is diverse but a few
general concepts are normally followed: (i) the metal ions
employed are often the same as in the native systems e.g. Ni(II)
in urease models;89 and (ii) pyridine or pyrazole residues are
often used to mimic the histidine residues in the enzymes;
phenol, carboxylate, pyrazolate or water molecules serve as
mimics for bridging residues like aspartate, lysine or water/
hydroxide; and (iii) dinucleating ligands are used to bring the
two metal ions into close proximity. The strategies for ligand
and complex design are diverse and have been recently
reviewed.90–93 A few reported structures of model complexes
for dinuclear hydrolytic enzymes are shown in Fig. 6.
As suggested biomimetics have helped to (i) characterise
intermediates in enzyme reactions, and (ii) provide structural
and mechanistic insights into the native systems. For example,
X-ray absorption near-edge spectroscopy data from Cd(II) thio-
late and imidazole complexes provided insight into the coordi-
nation number and nature of coordinating amino acids in the
Cd(II)-containing carbonic anhydrase of a marine diatom,
which suggested that the active site of this protein employs a
tetrahedral coordination geometry and that Cd(II) is bound to
a least one cysteine residue.94 A dicobalt(II) complex,
[Co2(μ-OH)(μ-Ph4DBA)(TMEDA)2(OTf)], (Ph4DBA is the di-
nucleating ligand dibenzofuran-4,6-bis(diphenylacetate)),
reported by Larrabee et al. is an excellent spectroscopic model
for the 5- and 6-coordinate sites of methionine aminopeptid-
ase and GpdQ.86–88,95 The magnetic exchange coupling from
this μ-OH bridged complex was determined to be ferro-
magnetic and the results from this study can be used to dis-
tinguish μ-aqua and μ-hydroxo bridging motifs in Co(II)Co(II)
enzyme systems.86,87 Neves et al. were able to synthesise, and
spectroscopically and kinetically characterise a dinuclear Fe(III)-
Zn(II) complex with a terminal Fe(III)-bound water molecule at
a position equivalent to that of the proposed nucleophile in
red kidney bean PAP.26 The phosphatase activity of this
complex yielded a bell-shaped, strongly pH-dependent rate
profile with a pH-optimum at 6.5, and pKa values of 5.3 and
8.1, demonstrating that this complex is an excellent structural
and functional model of the active site of PAPs.26
In order to generate structurally more relevant biomimetics
for dinuclear metallohydrolases much effort has been devoted
to the synthesis of asymmetric ligands considered to be more
suitable models for the asymmetric coordination environment
found in enzymatic systems. Nordlander et al. proposed that
asymmetric complexes are not only more appropriate func-
tional models for the active site of phosphoesterase enzymes,
but also that they exhibit enhanced catalytic rates compared
with their symmetric counterparts.15,19,20 Examples include
ligands employed to generate PAP,19,21,23,24,28,96–100 phospho-
esterase,101 urease,102,103 catechol oxidase104 and manganese
catalase biomimetics.105,106 Some ligands generate a hard and
a soft coordination site for the generation of heterodinuclear
model complexes for PAP metalloenzymes.24,96 In some cases
the ligands have one structural variation in one arm,23,24,96 in
others one donor arm has been omitted.19,104–106 Often the
vacant coordination site is found to be occupied by water or
solvent molecules in the complex.105,106
5.1 Dinuclear zinc hydrolase mimics
Zn(II) is a metal common in all forms of life; it is not only the
second most abundant metal in biological systems after iron,
but also occurs in the active site of over 200, mostly hydrolytic,
enzymes.107,108 It is suggested that the high occurrence of
Zn(II) in biological systems is due to the abundance of soluble
forms of this element in the environment.108 The advantages
of having Zn(II) in an active site of an enzyme include its high
Dalton Transactions Perspective
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Lewis acidity, which is mostly influenced by the ionic potential
Zeff/r (Zeff = effective electrical charge, r = effective radius of the
ion),108 and the coordination flexibility of Zn(II) arising from
its d10 configuration. However, this closed shell configuration
causes problems for the (bio)chemist studying Zn(II) systems
as this configuration is spectroscopically silent. The problem
is often solved by replacing, in vitro, Zn(II) with Co(II) or Cu(II)
and utilising the excellent spectroscopic properties of these
ions,109 or with Cd(II) and using 113Cd-NMR spectroscopy as a
probe.110 In addition to dinuclear Zn(II) hydrolases, mono- and
trinuclear enzymes are also common in nature.90 Among the
natural occurring Zn2/Zn3-enzymes are the phosphotriesterase
from Pseudomonas diminuta,111 the alkaline phosphatase,112
phospholipase C,113 P1 nuclease,114 the metallo-
β-lactamases115–117 and also some amino peptidases.118–121 A
few examples of the active sites in these enzymes are given in
Fig. 7. The structurally related, trinuclear representatives alka-
line phosphatase, phospholipase C and P1 nuclease all
possess an adjacent M(II) ion in close proximity to the dinuc-
lear Zn(II) site.90 Phospholipase C and P1 nuclease catalyse the
cleavage of phosphodiester bonds, while the alkaline phospha-
tase hydrolyses monoesters at both alkaline and acidic pH.90
The active nucleophile for alkaline phosphatases is believed to
be the serine residue activated by the second Zn(II) ion.31,90,112
Numerous research groups have reported Zn(II)Zn(II) hydro-
lase mimics.14–16,18,20,22,90,92,101,122–127 Bringing two Zn(II) ions
Fig. 6 Examples of dinuclear complexes mimicking hydrolytic enzymes.
Fig. 7 Commonly found zinc enzymes in nature.90,111–115,118
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in close proximity can be achieved with the help of bridging
ligands, like phenolate,101,128,129 carboxylate130 and pyrazolyl,17
or by incorporating them into a macrocycle (i.e. crown ether),
or, finally, by a simple aliphatic linker between two ligands,
each of them coordinating one Zn(II) ion.131 The rate enhance-
ment in phosphate ester hydrolysis by two Zn(II) ions (opposed
to catalysis by just one Zn(II) ion) was shown in a study by
Bazzicalupi et al.132,133 Employing the macrocyclic ligands LA
and LB (([30]aneN6O4) and [15]aneN3O2, respectively, Fig. 8), it
was demonstrated that the rate of hydrolysis of BPNPP under-
went a 10-fold increase by the dinuclear [Zn2LA(OH)2]
2+
opposed to the mononuclear [LBZn-OH]
+ complex.132 In an
attempt to crystallise [Zn2LA(OH)2]
2+ with diphenyl phosphate
a bridging coordination of the phosphate ester to the two
Zn(II) ions was found, further substantiating the necessity of
two Zn(II) ions during hydrolysis.132 The bidentate-bridging
binding mode of the diphenyl phosphate was also proposed in
solution using 31P-NMR measurements because of the rather
large shifts observed for the phosphate ester signal.132
The separation of the two zinc centres in the biomimetics
has been shown to be important. Meyer et al. correlated the
hydrolytic activity of dizinc phosphodiesterase models with
their Zn⋯Zn distances.16 Here, the length of the ligand side
chains determines the Zn⋯Zn separation. The distance of the
two Zn(II) ions in the complex with LG (N,N′-((1H-pyrazole-3,5-
diyl)bis(methylene))bis(2-(pyridin-2-yl)-N-(2-(pyridin-2-yl)ethyl)-
ethanamine) Fig. 8) is rather short with 3.479(1) Å, while the
metal ions are separated by 4.1518(6) Å with an analogous
ligand LF (N,N′-((1H-pyrazole-3,5-diyl)bis(methylene))bis-
(1-(pyridin-2-yl)-N-(pyridin-2-ylmethyl)methanamine.16 The
authors proposed that the separation of the Zn(II) centres is
significant in terms of the ability of the metal complexes to
efficiently catalyse the hydrolysis of the substrate, in this case
BPNPP.16 The kcat for the Zn(II) complex [Zn2(LFH−1)(MeOH)-
(OH)](ClO4)2, where the Zn(II) ions have a greater separation, is
2.3 × 10−5 s−1, greater than for the derivative with short
intramolecular distances [Zn2(LGH−1)(OH)](ClO4)2, kcat 4.9 ×
10−6 s−1.16 Kinetic studies of the hydrolysis of BDNPP and the
transesterification with the substrate 2-hydroxypropyl-p-nitro-
phenyl-phosphate (HPNP) utilising Zn(II) complexes of the
asymmetric ligand LK (2-(N-isopropyl-N-((2-pyridyl)methyl)amino-
methyl)-6-(N-(carboxylmethyl)-N-((2-pyridyl)methyl)amino-
methyl)-4-methylphenol, Fig. 8) and a similar symmetric
ligand showed that the more open coordination sphere in the
asymmetric ligand led to a five-fold enhancement of kcat.
18,20
In our work we have prepared a series of symmetric
and unsymmetric ligands and their di-Zn(II) complexes
(Fig. 9).101,134–139 These ligands were designed to study the
influence of groups in the para-position to the bridging pheno-
lic oxygen (CO2EtHL2, CH3HL2, NO2HL2 and BrHL2) on mag-
netism in the case of Co(II) complexes, and phosphoesterase
activity or to compare mechanistic implications of directly
Fig. 8 Overview of ligands for dinuclear phosphatase mimics: LA, LB
132,133:LC
188: LD
189:LE
189:LF
16:LG
189:LH
101:LI
126:LJ
21–24:LK
15,19,20; LL
28,96:LM.
190
Dalton Transactions Perspective
This journal is © The Royal Society of Chemistry 2014 Dalton Trans., 2014, 43, 910–928 | 917
Pu
bl
ish
ed
 o
n 
18
 O
ct
ob
er
 2
01
3.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f Q
ue
en
sla
nd
 on
 12
/10
/20
15
 02
:10
:48
. 
View Article Online
bound groups like methyl ether and alcohol (CO2EtH3L1 and
CO2EtHL2), in addition to a study of steric influences of bulky
ligands arms by comparing complexes of CH3HL2 and
CH3HL3.
134–139 The pyridine residues are mimics for histidine,
and the alcohol and ether-arms are mimicking asparagine and
aspartate residues, present in enzyme active sites. The brid-
ging phenol mimics a bridging aspartate or hydroxide. The
coordination sphere in the metal complexes is predominantly
completed by bridging acetato ligands. Some ligands feature
functional groups (CO2HH3L1, NH2HL2, CO2HHL6 and
CH3H2L4) which allow attachment of the ligands to resins, in-
organic supports such as silica, Merrifield resin and magnetite
nanoparticles.134,140 Mass spectrometry in the presence and
absence of substrates, 1H, 13C and 31P NMR including
18O-labeling studies, X-ray crystallography and kinetic assays
were employed to address questions like substrate binding
mode, nucleophiles in OP hydrolysis and in-solution structure
of the Zn(II) complexes.
para-Substituents to the bridging phenolic oxygen were
found to influence the Zn⋯Zn distances in these complexes to
a very small extent.139 The Zn⋯Zn distance in the most
strongly electron withdrawing NO2L2 ligand was slightly
elongated (3.341 Å) compared to the BrL2 (3.304 Å) and CH3L2
(3.296 Å) analogues. The Zn–O–Zn angle of the L2 series
ligands is similar and close to a perfect tetrahedral angle while
for the L3 ligand with the bulky phenyl ether arms enforces a
larger deviation from 109° (107.49°).139
Phosphatase-like activities of the di-Zn(II) complexes were
measured using the activated substrate BDNPP over a pH
range 5–10.5.139 The data are shown in Table 2. The rate (ν0)
vs. pH profiles for three of the Zn(II) complexes, [Zn2(CH3L2)-
(CH3COO)2](PF6), [Zn2(CH3L3)(CH3COO)2](PF6), and [Zn2(BrL2)-
(CH3COO)2](PF6), were consistent with the presence of two pro-
tonation equilibria and were fitted to bell-shaped curves.
[Zn2(CH3L2)(CH3COO)2](PF6) and [Zn2(CH3L3)(CH3COO)2](PF6)
exhibited similar catalytic behaviour; the least efficient
Fig. 9 Overview of the ligands synthesized in our work.101,134–139
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complex was [Zn2(NO2L2)(CH3COO)2](PF6). Overall the kcat and
catalytic efficiency of these complexes were comparable to
similar systems (Table 2). The most interesting result of the
change of para-substituent was the effect on rate of hydrolysis
of the substrate. A linear correlation between the Hammett
parameter σ for the substituent (CH3–, NO2– and Br–) and log
(kcat) was found suggesting that for these complexes the catalytic
efficiency could be manipulated by judicious choices of substi-
tuent.139 A similar effect has been reported in a PAP model with
a Fe(III)Zn(II) centre.141 In neither case, however, were similar
correlations found with Km suggesting that the substituent in
para-position is primarily affecting nucleophilic activation.
The nucleophile in zinc complex-catalysed hydrolysis reac-
tions is in most cases proposed to be a terminal water mole-
cule (pKa = 6.60–9.5; (A) and (B) in Fig. 10).
101,142 If the
complex contains an additional alcohol moiety the assign-
ment of the hydrolysis-initiating nucleophile can be
ambiguous.126,142 In monomeric Zn(II) systems it was pro-
posed, based on DFT calculations and reactivity studies, that a
metal bound alkoxide is more reactive than a water mole-
cule.31,143,144 Deprotonation constants of water bound to free
Zn(II) have been observed to range from 8.2–9.2,145 whereas the
pKa of a zinc-bound alcohol was shown to be around 7.2.
126,142
A bridging hydroxide was initially proposed in the zinc
complex (Fig. 10C). The authors, however, proposed that the
bridging hydroxide acts as a general base to activate an exter-
nal water molecule.146 The pKa of 7.31 was assigned to the
zinc-bound alcohol-arm in complex (Fig. 10D). However, the
authors did not indicate how the catalyst is recovered after
nucleophilic attack of the ligand arm.126 The di-Zn(II) com-
plexes in our work were also probed to determine the active
nucleophile. Use of 50/50 mixture of 18O–16O water and 31P
NMR were employed to investigate the mechanism of phospho-
esterase activity of these complexes, specifically the role of the
Table 2 Kinetic properties of some Zn(II)Co(II) and Cd(II) phosphoesterase mimics
Complexb kcat [s
−1] Km [mM] Substrate pH optimum T [K] Solvent system Kinetic pKa
[Zn2LA-2H(OH)2]
2+132,133 1.15 × 10−4a — BPNPP 10.5 308 Water ∼9.5
[ZnLB(OH)2]
2+132,133 1.31 × 10−5a — BPNPP 10 308 Water ∼8.9
[Zn2(LCH-2)]
188 2.24 × 10−6 12 BPNPP 9.73 308 Water —
[Zn2(LDH−1)(MeOH)(OH)](ClO4)2
189 1.9 × 10−6 42 BPNPP 8.28 323 DMSO–water 1 : 1 7.57
[Zn2(LEH−1)]
189 4.2 × 10−5 55 BPNPP 8.28 323 DMSO–water 1 : 1 7.66
[Zn2(LFH−1)(MeOH)(OH)](ClO4)2
16 2.3 × 10−5 56 BPNPP 8.28 323 DMSO–water 1 : 1 7.60
[Zn2(LGH−1)(OH)](ClO4)2
16 4.9 × 10−6 51 BPNPP 8.28 323 DMSO–water 1 : 1 7.96
[Zn2(LHH−2)(OAc)](PF6)
101 1.26 × 10−6 1.96 BPNPP 9.0 323 CH3CN–water 1 : 1 7.87
[Zn2(LIH−2)(OAc)(H2O)](PF6)
126 4.6 × 10−6 61.5 BDNPP 7.2 323 DMSO–water 3 : 7 7.31
[Zn2(LJH−1)(OH)]
2+ 22 6.4 × 10−4 13.5 HPNP — 298 DMSO–water 3 : 7 7.4
[(Zn2(LKH−2)(OAc))2](PF6)2
20 1.2 × 10−4 3.6 HPNP 8.5 298 CH3CN–water 1 : 1 ∼8.5
[(Zn2(LKH−2)(OAc))2](PF6)2
20 6.4 × 10−4 16 BDNPP 8.5 298 CH3CN–water 1 : 1 6.63
[Zn2(CH3L2)(CH3COO)2](PF6)
138 5.70 × 10−3 20.8 BDNPP 8.8 298 CH3CN–water 1 : 1 6.76, 11.00
[Zn2(BrL2)(CH3COO)2](PF6)
138 0.76 × 10−3 6.5 BDNPP 8.8 298 CH3CN–water 1 : 1 6.55
[Zn2(NO2L2)(CH3COO)2](PF6)
138 1.90 × 10−3 7.1 BDNPP 9.5 298 CH3CN–water 1 : 1 6.56, 10.60
[Zn2(CH3L3)(CH3COO)2](PF6)
138 3.60 × 10−3 18.9 BDNPP 8.5 298 CH3CN–water 1 : 1 7.72, 10.83
[Zn2(CH3L4)(CH3COO)2](PF6)
138 2.45 × 10−3 9.48 BDNPP 7.7 298 CH3CN–water 1 : 1 7.39
[Zn2(CH3L5)(CH3COO)2](PF6)
138 0.97 × 10−3 7.01 BDNPP 7.7 298 CH3CN–water 1 : 1 7.50
[Co2(CO2EtH2L1)(CH3COO)2](PF6)
135 9.12 × 10−3 3.26 BDNPP 10.70 298 CH3CN–water 1 : 1 10.54
[Co2(CO2EtH2L1)(CH3COO)2](PF6)
135 9.12 × 10−3 3.26 BDNPP 10.70 298 CH3CN–water 1 : 1 10.54
[Co2(CO2EtL2)(CH3COO)2](PF6)
135 11.40 × 10−3 4.31 BDNPP 10.40 298 CH3CN–water 1 : 1 8.34
[Co2(CH3L2)(CH3COO)2](PF6)
135 5.48 × 10−3 4.48 BDNPP 11.00 298 CH3CN–water 1 : 1 8.53
[Co2(NO2L2)(CH3COO)2](PF6)
135 9.23 × 10−3 6.83 BDNPP 9.55 298 CH3CN–water 1 : 1 8.12
[Co2(BrL2)(CH3COO)2](PF6)
135 19.10 × 10−3 4.62 BDNPP 10.00 298 CH3CN–water 1 : 1 8.75
[Cd2((HP)2B)(CH3COO)2(OH2)](PF6)
138 3.8 × 10−3 8.4 BDNPP 10.5 298 CH3CN–water 1 : 1 8.9
[Cd2(CO2EtH2L1)(CH3COO)2](PF6)
138 9.4 × 10−3 9.4 DNPP 10.4 298 CH3CN–water 1 : 1 10.11
a Second order rate constants in [M−1 s−1]. b The structures of these ligands are shown in Fig. 8 and 9.
Fig. 10 Different hydrolysis initiation nucleophiles found in dinuclear Zinc(II) complexes.
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potential alkoxide nucleophiles in the reaction. 31P-chemical
shifts are very sensitive to structural changes arising from an
18O bound to the phosphorus instead of an 16O; the signal
arising from 18O is thus shifted to lower frequency.147–149 For
complexes utilising a nucleophile arising from a coordinated
aqua ligand in a 50 : 50 18O–16O environment is it expected
that the product of the hydrolysis reaction will be found with
50% 18O incorporated from the nucleophile.147–149 The obser-
vation in the 31P spectrum of a splitting of the product peak
into a doublet (peak separation of approximately 0.02 ppm)
thus reflecting the 16O/18O substitution suggests that for com-
plexes such as for [Zn2(CH3L2)(CH3COO)2](PF6) and
[Zn2(CH3HL1)(CH3COO)-(H2O)](PF6) the nucleophile is a Zn(II)
bound water/hydroxide from the solvent. The proposed mecha-
nism is shown in Fig. 11. However, the dual action of both the
alkoxide and hydroxide nucleophiles cannot be dismissed as a
possible mechanistic pathway for these complexes.
5.2 Dinuclear cadmium hydrolase mimics
Cadmium gained its name from the Greek word “kadmeia”,
an ancient name for Zn(II) oxide.150 Cadmium is similar in
some ways to Zn(II) and the most common oxidation state is
Cd(II). In coordination compounds Cd(II) is often found hepta-
coordinate80,151,152 and it is often used as a probe for struc-
tural and mechanistic studies of proteins in which Zn(II) is
substituted by Cd(II) in their active centres. Often a higher
hydrolytic activity is found than in the corresponding Zn(II)
enzymes and complexes.80 The natural abundance of 113Cd is
12.22%153 and it is very sensitive to environment changes due
to the large surrounding electron cloud. It is also a spin 1/2
nucleus which generally yields sharp NMR signals, making
113Cd NMR spectroscopy a useful method for structure elucida-
tion in biological, inorganic and organometallic cadmium-
containing samples.110,154 Cd(II) is known to be extremely toxic
to mammals, hence it is generally viewed as an element that is
not used by nature. However, in 2005 Morel and co-workers
reported an investigation of a metalloenzyme from Thalassio-
sira weissflogii, a marine phytoplankton, which specifically
uses Cd(II) to achieve its biological function.155,156 Following
X-ray absorption near-edge spectroscopy and comparison with
Cd(II) thiolate and imidazole complexes the authors suggested
that the Cd(II) containing active site of this protein employed a
geometry close to the tetrahedral coordination found in a
Zn(II)-containing class of carbonic anhydrases in higher plants
and, moreover, that Cd(II) was bound to a least one cysteine
residue.156,157 A subsequent crystal structure of this enzyme
showed that indeed Cd(II) was coordinated by two cysteine and
one histidine residues.156 The tetrahedral coordination of
Cd(II) was completed by a water molecule which is connected
to an extensive and well-ordered water hydrogen bond network
around the active site.
Biomimetic Cd(II) complexes which mimic either structural
or functional aspects of their enzymatic counterpart are rare in
the literature and mostly based on mimicking mononuclear
enzymes like alcohol dehydrogenase and carbonic
anhydrase.124,152,157–162 Di- and multinuclear Cd(II) complexes
are mostly studied in terms of their NMR-shift, structure and
coordination number.151,152,163–165 For GpdQ we reported a
comparative study of its Cd(II) derivative and a biomimetic.80
The structure of the model complex [Cd2((HP)2B)-
(CH3COO)2(OH2)]PF6 ((HP)2B = 2,6-bis([(2-pyridylmethyl)-
(2-hydroxyethyl)amino]methyl)-4-methylphenol) is depicted in
Fig. 12; the ligand mimics the N,O donor atoms of the active
site of the enzyme GpdQ (Fig. 12, right). The X-ray structure of
[Cd2((HP)2B)(CH3COO)2(OH2)]PF6 shows that one Cd(II) ion is
seven-coordinate with two nitrogen donors and an oxygen
donor from one binding site of the ligand, an oxygen donor
from the bridging oxygen of the ligand, two oxygen donors
from bidentate acetate and an oxygen donor from a bound
water molecule.80 This is an important feature, as a terminal
Fig. 11 The different nucleophiles involved in phosphoester cleavage in [Zn2(CH3HL1)(CH3COO)(H2O)](PF6) and Zn2(CH3L2)(CH3COO)2](PF6).
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water molecule is the likely nucleophile in GpdQ.38,77 Remark-
ably, potentiometric studies showed that the two Cd(II) ions
show different binding affinities, with log K1 = 13.6 and log
K2 = 3.2, mimicking the different affinities found for the native
enzyme.38,77,80 The phosphoesterase-like activity of the bio-
mimetic was studied utilising the substrate BDNPP and yielded
a kinetic pKa of 8.9, with kcat = 0.004 s
−1. In the same work,
studies of Cd2-GpdQ and the phosphodiester substrate bis-
(4-nitrophenyl)phosphate (BPNPP) resulted in a kcat of 15 s
−1 and
a catalytically relevant pKa of 9.4.
80 For both the biomimetic
and the enzyme, a terminal hydroxide is implicated as the
catalytic nucleophile. Another mechanistic study of a Cd(II)-
substituted phosphoesterase has been reported by Ely et al.71
The kinetically relevant pKa (∼4–5) for Cd2-OpdA (organophos-
phate-degrading agent) in the hydrolysis of ethyl paraoxon
suggested a bridging hydroxide as the nucleophile.71
We have investigated the cadmium(II) complexes of other
ligands. The absence of a metal bound alcohol in
[Cd2(CO2EtL2)(CH3COO)2]
+ (an “ether-arm” complex) allows
the assignment of the kinetically relevant pKa (8.7) to a metal-
bound terminal water molecule as found in related Zn(II) com-
plexes.138,142 The higher pKa opposed to the Zn(II) systems is
attributed to the less acidic character of the Cd(II) ion.32 Inter-
estingly, previous studies of similar Zn(II) complexes have
shown that the pKas of the ether- and alcohol-ligand catalysed
reaction are often found to be similar within error suggesting
that the same nucleophile is present.138 It is known that for
[Cd2(CO2EtL2)(CH3COO)2]
+ the ether-arms are only partially
coordinated in solution whereas the donors in
[Cd2(CO2EtH2L1)(CH3COO)2]
+ (an “alcohol-arm” complex)
should be more tightly bound.126,138 Thus, in the mechanism
proposed for [Cd2(CO2EtL2)(CH3COO)2]
+, a nucleophile (termi-
nal water/hydroxide) or substrate molecule could replace an
ether-arm, whereas in the mechanism with [Cd2(CO2EtH2L1)-
(CH3COO)2]
+ the alcohol-arms are bound more tightly restrict-
ing the geometry of the complex somewhat so that the pKa of
terminal water molecule is shifted to a more alkaline region.
Another scenario is that the alcohol-arm of the complex with
EtCO2H3L1 is acting as general base. Lippard and coworkers
reported a Zn(II) complex with a bridging hydroxide where the
nucleophile was an external water (pKa = 7.06) activated by the
bridging hydroxide as base.146 The pKa of 10.1, however, would
be unusually high for a Cd(II)-bound alcohol. An 18O-labeling
experiment suggests that the nucleophile in OP hydrolysis by
[Cd2(CO2EtH2L1)(CH3COO)2]
+ is not a ligand centred alkoxide
but rather a water molecule which is terminally bound to one
Cd(II) ion.138 It is thus proposed that in both complexes the
acting nucleophile is terminally bound water (Fig. 13A and B).
The difference in pH is attributed to subtle structural and
electronic differences in the complexes. In [Cd2(CO2EtL2)-
(CH3COO)2]
+ a terminally Cd(II)-bound water (pKa = 8.7) is repla-
cing one of the ether-arms, in [Cd2(CO2EtH2L1)(CH3COO)2]
+,
however, the alcohol-arm is bound tightly to the Cd(II) ions and
thus the terminal water has to compete with the ligand donor
atoms for coordination. Other mechanistic scenarios are possi-
ble. One would be where the alcohol-arm of the ligand is
actively involved in the mechanism. In this case it could be envi-
saged that the alcohol-arm is deprotonated at pH 10.1 and acts
as the primary nucleophile to hydrolyse the substrate BDNPP.
The ligand is then recovered by an external water molecule and
the substrate is released. A second scenario is possible where,
upon deprotonation, the alkoxide acts as a general base to acti-
vate an external water molecule which then hydrolyses the sub-
strate. Both scenarios would be consistent with the finding of a
50% 18O labeled DNPP (Fig. 13C and D).147–149 Data related to
the activity of these Cd(II) complexes is presented in Table 2.
The higher activity and the difference in pH dependence of
[Cd2(CO2EtH2L1)(CH3COO)2]
+ opposed to the complex
[Cd2((HP)2B)(CH3COO)2(OH2)]PF6 may be attributed to the
ethyl ester group in para-position of the bridging phenolic
oxygen.80,138 This effect is analogous to the effect of the para-
substituents seen in the di-Zn(II) complexes. The latter
complex with the same donor atom set as the former but a
methyl group in para-position of the bridging phenolic oxygen,
exhibited a pKa around 9,
80 suggesting that the ethyl ester has
an effect on the polarization of the nucleophile, shifting the
catalytically relevant pKa. Peralta et al. reported a linear corre-
lation between the pKa values attributed to deprotonation of
the Fe(III)-bound water for complexes with different substitu-
ents, methyl, H, Br and NO2 respectively.
141 These studies
Fig. 12 The structure of [Cd2((HP)2B)(CH3COO)2(OH2)]PF6
80 Counter ion and hydrogen atoms have been omitted for clarity. Left: the dinuclear
active site of GpdQ.38
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suggest that subtle structural changes in the ligand can influ-
ence catalytic activity and the acidity of the Cd(II) ions in
nucleophilic activation.
5.3 Dinuclear cobalt hydrolase mimics
Cobalt is a transition metal that is less abundant in nature
than most other first row transition metals.166 However, as a
cofactor for vitamin B12 it is an essential trace element for
humans.167 Cobalt is usually found to be coordinated by a
corrin ligand backbone in natural systems and one of the few
true organometallic compounds in nature is the Co(III)-alkyl
group in vitamin B12.
168 A few Co(II)-containing enzymes such
as prolidase, nitrile hydratase, bromoperoxidase or glucose iso-
merase have been isolated from bacteria.167 Co(II) is, however,
extensively used as spectroscopic probe for Zn(II)-containing
enzyme active sites due to its unique spectroscopic and
Fig. 13 Proposed mechanism for the BDNPP hydrolysis by [Cd2(CO2EtH2L1)(CH3COO)2]
+ (A) and [Cd2(CO2EtL2)(CH3COO)2]
+ (B). Possible alterna-
tive mechanisms involving the alkoxide as a nucleophile that could lead 18O being incorporated in the hydrolysis product (C and D).
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magnetic properties. Often the catalytic activity in the cobalt
substituted protein is retained,109 and the active site geometry
employed by Co(II) is frequently found to be virtually identical
to the Zn(II) enzymes.109 Octahedral or tetrahedral geometries
are easily distinguished in the electronic absorption spectra,
with the absorption band of the octahedral Co(II) displaying a
characteristic splitting from spin–orbit coupling.88
As for Co(II)-metalloenzymes the MCD of Co(II)-containing
model complexes is extremely useful. A number of dinuclear
Co(II) complexes have been studied by MCD,86,87,95 and with
the aid of VTVH MCD magnetic coupling parameters have
been obtained,86 complementing magnetic susceptibility
measurements. Distinct transitions for 4- (negative band a
600 ± 50 nm and less intense positive band at 525 ± 50 nm),
5- (negative bands between 650 and 450 nm) and 6-coordinate
Co(II) (sharp negative band around 500 ± 50 nm) can be
assigned.88 Band intensities can also be an indicator for the
coordination number of a Co(II) ion.88 While 4- and 5-coordi-
nate Co(II) displays bands of substantial intensity at room
temperature the transitions from 6-coordinate Co(II) are up to
ten times less intense. At very low temperature, however, the
latter are often more intense than 5-coordinate transitions.
Fitting of experimental susceptibility data and explaining
the magnetic properties for Co(II) systems is a challenging
endeavor.86,169–173 High spin (perfect) octahedral Co(II) dis-
plays 4T1g symmetry in the ground state and the susceptibility
often shows considerable temperature dependence; the
interpretation of data is difficult due to a partial quenching of
the angular orbital momentum and to large spin orbit coup-
ling resulting in substantial zero field splitting causing high
magnetic anisotropy.169,174 Zero field splitting parameters (D)
can be measured by VTVH MCD and their magnitude provides
valuable information about the coordination number and geo-
metry of paramagnetic metal ions.88 An important parameter
in dinuclear Co(II) systems is the magnetic exchange coupling
( J). Larrabee et al. reported a range of dinuclear Co(II)Co(II),
Co(II)Co(III) and Co(III)Co(III) complexes to provide insight into
the electronic structure and reactivity of cobalt substituted
EcMetAp (methionine aminopeptidase from Escherichia
coli).86,95 By studying these models the authors were able to
develop a method to distinguish between µ-aqua and
µ-hydroxo species in related enzymes. By comparing the
J values obtained by VTVH-MCD measurements the authors
found that µ-aqua complexes display, in general, a greater
J value and can thus be distinguished from µ-hydroxo com-
plexes.87,95 A Co(II) complex employing a mixed 5- and
6-coordination sphere which proved to be an excellent spectro-
scopic model not only for Co(II)-substituted methionine
aminopeptidase but also for the enzyme GpdQ and other
dinuclear metalloenzymes was reported by Larrabee and co-
workers.87 The authors gained insight about the potential
nucleophile in hydrolysis of phosphate esters by comparing
the J values.87 The trend that µ-hydroxo structures have posi-
tive J values and are ferromagnetically coupled and µ-aqua
bridged derivatives exhibit weak antiferromagnetic (negative
J values) or no coupling, was observed.87 Susceptibility studies
of a series of dicobalt(II) complexes based on the ligands
shown in Fig. 9 indicate very weak antiferro- or ferro-magnetic
coupling between the two Co(II) sites; DFT calculations were
unable to explain the differences in the coupling although did
suggest that the major pathway for the interaction was through
the phenoxo donor and there were no consistent trends based
on structural parameters to explain the variations in both the
sign and magnitude of the coupling in a range of dinuclear
Co(II) complexes.134
5.4 Mechanism of phosphodiester hydrolysis for the Co(II)
complexes
In a prescient study, one of the first synthetic compounds
capable of phosphate ester cleavage via a dinuclear metal
centre was reported in 1984 by Sargeson (Fig. 14).175 The pres-
ence of a second Co(III) centre in this complex was suggested
to be responsible for a 26-fold increase in the rate of hydrolysis
compared to that observed for the corresponding mononuclear
complex.175 It was proposed that the coordinated 4-nitro-
phenylphosphate (PNPP) was cleaved by an intramolecular
attack of a terminal bound hydroxide. Since Sargeson’s early
work other examples of functional or spectroscopic model
complexes for several dicobalt(III)/(II) complexes have been
reported.149,176–185
For the Co(II) complexes in the present studies the activity
towards organophosphoesters using BDNPP, was investigated
(Table 2).136 All complexes are good functional mimics for
phosphodiesterases and show one pKa relevant for hydrolysis.
For the complexes with the methyl-ether donor, the absence of
an alkoxide nucleophile and the kinetically relevant pKa in the
range 8.12–8.75 suggests that a terminal water molecule bound
to Co(II) is the active nucleophile. For [Co2(CO2EtH2L1)-
(CH3COO)2](PF6), fitting of the data resulted in a pKa of 10.5.
For this complex, as with previous studies with this type of
ligand, the possibility exists that the alkoxide may be the active
nucleophile. However, the pKa of 10.5 for this complex is still
in the range of that for a Co(II)-OH2,
145 and hence the identity
of the nucleophile is uncertain. What is apparent is that the
catalytic activity of the Co(II) complexes towards the substrate
BDNPP is similar to that displayed by the analogous Zn(II)
complexes although it does not approach the efficiency of
Co(II)2-GpdQ (kcat = 1.62 s
−1, kcat/Km = 1.16 mM
−1 s−1).38
Fig. 14 Phosphate ester cleavage by a dinuclear Co(III) complex.
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6. Conclusion
The enzyme GpdQ has shown itself to be a fertile source for
the investigation of structure and function but also as an inspi-
ration to develop model systems which have some properties
consistent with those displayed by the enzyme itself. In terms
of GpdQ itself, future work could include optimization and
testing of both mutant and wild type systems on a range of
pesticides and nerve agents. Our studies of a number of Zn(II),
Cd(II) and Co(II) of variously substituted dinucleating ligands
have allowed the investigation of the impacts of ligand modifi-
cations on the phosphoesterase mechanism, as well as inten-
sive analysis of the relevant spectroscopic data arising from
these complexes. Where appropriate the properties of these
model systems have been related back to the enzyme systems.
Our most recent work has explored ligands which mimic the
asymmetric coordination environment of GpdQ more accu-
rately.134 The zinc(II) complexes in the crystal structure display
a 5,6-coordination sphere, mimicking the coordination
arrangement of GpdQ, this is not the case for the solution
structure. The complexes were shown to be less active than
substances based on symmetric ligands. We have also recently
explored the immobilization of both GpdQ and model systems
on solid supports, Merrifield resin and magnetite nanoparti-
cles.140 The complexes were shown to be active towards organo-
phosphates and provide promising systems for the use in filter
systems. The challenge is now to enhance activity of GpdQ and
biomimetics towards commonly used pesticides. Given the
importance of stability, the model complexes could be good
alternatives to the enzyme systems. However, their activity needs
to be enhanced towards ‘real life substrates’. This remains the
challenge for the development of true enzyme models.
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